🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 8 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/04/2018 27,50 28,60 27,10 28,00 +1,82% 5,45% 1.376.600
02/04/2018 30,75 31,10 26,95 27,50 -11,72% 13,50% 2.208.800
29/03/2018 30,95 31,50 30,40 31,15 +0,65% 3,55% 789.800
28/03/2018 31,60 32,05 30,70 30,95 -1,43% 4,27% 626.400
27/03/2018 31,95 32,25 31,05 31,40 -1,26% 3,76% 610.100
26/03/2018 32,75 32,75 31,48 31,80 -1,55% 3,88% 796.800
23/03/2018 32,05 32,65 31,55 32,30 +0,94% 3,43% 823.700
22/03/2018 32,20 32,75 31,15 32,00 -0,78% 4,97% 916.200
21/03/2018 29,90 32,40 29,35 32,25 +7,57% 10,20% 1.466.700
20/03/2018 30,65 31,25 29,05 29,98 -2,28% 7,18% 957.900
19/03/2018 29,40 30,75 27,80 30,68 -0,71% 10,03% 2.311.300
16/03/2018 30,15 31,05 30,15 30,90 +2,49% 2,99% 1.023.400
15/03/2018 30,45 30,60 29,65 30,15 -1,31% 3,12% 832.000
14/03/2018 31,90 32,15 29,70 30,55 -4,08% 7,68% 853.800
13/03/2018 32,25 33,15 31,65 31,85 -1,24% 4,65% 1.248.800
12/03/2018 31,95 32,75 31,25 32,25 +1,10% 4,69% 809.200
09/03/2018 31,75 32,25 31,30 31,90 +0,63% 2,99% 451.000
08/03/2018 31,60 32,05 31,25 31,70 +0,16% 2,53% 457.400
07/03/2018 31,25 32,10 30,75 31,65 +0,86% 4,32% 528.800
06/03/2018 31,85 32,25 31,05 31,38 -1,57% 3,77% 1.022.200
05/03/2018 33,25 33,55 31,35 31,88 -4,12% 6,62% 961.800
02/03/2018 32,35 33,65 32,00 33,25 +1,68% 5,10% 723.600
01/03/2018 31,00 33,45 30,90 32,70 +4,47% 8,23% 1.143.300
28/02/2018 31,80 32,65 30,55 31,30 +0,32% 6,60% 1.251.400
27/02/2018 31,95 32,40 30,80 31,20 -1,89% 5,01% 967.900
26/02/2018 31,45 32,25 31,00 31,80 +1,76% 3,97% 640.400
23/02/2018 30,90 31,35 30,30 31,25 +2,29% 3,40% 684.400
22/02/2018 30,30 30,85 29,65 30,55 +1,33% 3,96% 845.700
21/02/2018 30,85 31,65 30,00 30,15 -3,52% 5,35% 835.200
20/02/2018 29,70 31,95 29,65 31,25 +3,65% 7,74% 1.119.700